N-(1,3,4-Thiadiazol-2-yl)nicotinamide hydrochloride, 97%, 1g

7-Hydroxyindole-2-carboxylic acid, 97.0%, 10g

2-Bromo-6-fluoro-4-methylpyridine, 95.0%, 10g

Plan PLPHi S40x/0.65 phase contrast IOS infinity corrected objective

6-Methyl-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-2-ylamine, 96%, 1g

N-TERT-BUTYL-5-METHYLISOXAZOLIUM PERCHLORATE, 98%, 1g

ethyl 2,4-dibromo-1H-imidazole-5-carboxylate, 97%, 100mg

2-BOC-2-AZASPIRO[3.5]NONANE-7-METHANOL, 95.0%, 250mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl Bromide>98.0%(GC)(T)5g

1-(2-FLUORO-6-METHOXYPHENYL)ETHAN-1-AMINE, 95%, 250mg

4-Quinazolinamine, 6,7-dimethoxy-N-phenyl-, 97%, 250mg

Strontium oxide 99.5% 50 g

(1H-Benzo[d]imidazol-2-yl)methanamine hydrochloride, 95.0%, 25g